Home > Request Information
Title:
APEIRON Biologics Commences Clinical COVID-19 Trial with Inhaled APN01 
* Company:
* Country:
* Name:
Job Title:
* Tel:
Fax:
* E-mail:
Message:
Verification Code:
refresh